The effect of citalopram versus a placebo on central auditory processing in the elderly.
Jose Fernando Polanski
60 participants
Oct 19, 2015
Interventional
Conditions
Summary
Elderly with 60 years or more, with hearing impairment detected and confirmed by poor performance in Central Auditory Processing tests. 60 Subjects will be divided into two groups and given citalopram 20 mg/day or placebo for 6 months. Hearing evaluation will be performed initially and after 6 months and will include pure-tone audiometry, speech discrimination test (SDT), emittanciometry, hearing handicap inventory for elderly test (HHIE), minimental cognitive test and Central Auditory Processing evaluation.
Eligibility
Inclusion Criteria1
- Subjects with hearing threshold from normal to moderate loss and with low performance in central auditory processes tests.
Exclusion Criteria1
- Contraindications for the drug (citalopram).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
citalopram 20 mg/day, in oral capsule, for 6 months; Medical consultation every 2 months for drug delivery. At same time, the adherence will be evaluated as well as collateral effects or even other clinical benefits from the drug.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12614000570684